Title:
USE OF ADENO-ASSOCIATED VIRUSES FOR DECREASING THE RADIOTHERAPY-INDUCED OR CHEMOTHERAPY-INDUCED RESISTANCE IN CANCER PATIENTS
Document Type and Number:
WIPO Patent Application WO1999064024
Kind Code:
A3
Abstract:
The invention relates to the use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in patients who suffer from a cancer which is to be treated by radiotherapy or chemotherapy.
More Like This:
Inventors:
VON KNEBEL-DOEBERITZ MAGNUS (DE)
KLEIN-BAUERNSCHMITT PETRA (DE)
ZUR HAUSEN HARALD (DE)
SCHLEHOFER JOERG (DE)
KLEIN-BAUERNSCHMITT PETRA (DE)
ZUR HAUSEN HARALD (DE)
SCHLEHOFER JOERG (DE)
Application Number:
PCT/DE1999/001711
Publication Date:
March 09, 2000
Filing Date:
June 08, 1999
Export Citation:
Assignee:
DEUTSCHES KREBSFORSCH (DE)
VON KNEBEL DOEBERITZ MAGNUS (DE)
KLEIN BAUERNSCHMITT PETRA (DE)
ZUR HAUSEN HARALD (DE)
SCHLEHOFER JOERG (DE)
VON KNEBEL DOEBERITZ MAGNUS (DE)
KLEIN BAUERNSCHMITT PETRA (DE)
ZUR HAUSEN HARALD (DE)
SCHLEHOFER JOERG (DE)
International Classes:
A61K35/76; A61P35/00; (IPC1-7): A61K35/76
Domestic Patent References:
WO1996018737A2 | 1996-06-20 |
Other References:
KLEIN-BAUERNSCHMITT P ET AL: "Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells.", EUROPEAN JOURNAL OF CANCER, (1996 SEP) 32A (10) 1774-80., XP000867207
HILLGENBERG M ET AL: "Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2.", EUROPEAN JOURNAL OF CANCER, (1999 JAN) 35 (1) 106-10., XP000867208
HILLGENBERG M ET AL: "Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2.", EUROPEAN JOURNAL OF CANCER, (1999 JAN) 35 (1) 106-10., XP000867208
Download PDF:
Previous Patent: LACTIC ACID BACTERIUM-CONTAINING COMPOSITIONS, DRUGS AND FOODS
Next Patent: PROTECTING NEURONS FROM ISCHEMIA
Next Patent: PROTECTING NEURONS FROM ISCHEMIA